↓ Skip to main content

How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer’s disease?

Overview of attention for article published in Expert Opinion on Emerging Drugs, January 2024
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
1 Dimensions
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer’s disease?
Published in
Expert Opinion on Emerging Drugs, January 2024
DOI 10.1080/14728214.2024.2304059
Pubmed ID
Authors

Jordan Beveridge, Eileen Kaniecki, Aniketh Naidu, Bret David Silverglate, George Grossberg

Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 January 2024.
All research outputs
#4,819,991
of 25,381,783 outputs
Outputs from Expert Opinion on Emerging Drugs
#73
of 522 outputs
Outputs of similar age
#57,658
of 290,247 outputs
Outputs of similar age from Expert Opinion on Emerging Drugs
#2
of 9 outputs
Altmetric has tracked 25,381,783 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 522 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,247 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.